MiR-199a-5p Deficiency Promotes Artery Restenosis in Peripheral Artery Disease by Regulating ASMCs Function via Targeting HIF-1α and E2F3.
Duan LiuYexiang JingGuiyan PengLitai WeiLiang ZhengGuangqi ChangMian Wang
Published in: Current vascular pharmacology (2024)
MiR-199a-5p exhibits promise as a prospective therapeutic target for RS since it alleviates the condition by inhibiting the proliferation and migration of ASMCs via its regulation of HIF-1α and E2F3.